Cambium Bio Revenue

Biotechnology Research • Sydney, New South Wales, Australia • 1-10 Employees

Cambium Bio revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	No funding

Key Contact at Cambium Bio

Karolis Rosickas

Chief Executive Officer

Company overview

Headquarters	16 Goodhope St, Paddington, New South Wales 2021, AU
Phone number	+616788603725
Website	cambium.bio
NAICS	541714
Employees	1-10
Socials

About Cambium Bio

Cambium Bio Limited (ASX:CMB) is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue regeneration applications. The Company's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics with a primary focus on ophthalmology. Cambium Bio's lead product candidate, Elate Ocular®, is being developed to address significant unmet medical needs in the treatment of dry eye disease. In addition, the Company's stem cell platform, Progenza™, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. Cambium Bio is committed to advancing its pipeline through clinical development and commercialization, with the goal of providing transformative treatments to improve patient outcomes. For more information about the Company and its programs, please visit www.cambium.bio

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Employees by Department

Cambium Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Cambium Bio has never raised funding before.

Frequently asked questions

Cambium Bio is located in Sydney, New South Wales, AU.

You can reach Cambium Bio at +616788603725.

Cambium Bio generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Cambium Bio has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cambium Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Cambium Bio

Karolis Rosickas

Chief Executive Officer

4.8

40,000 users